News | September 14, 2024
Briefs: RPG Life Sciences and Lasa Supergenerics
Lasa Supergenerics Limited has been granted patent for an invention “Processes for Preparation and Purification of 5-Chloro-2-Nitroaniline
Lasa Supergenerics Limited has been granted patent for an invention “Processes for Preparation and Purification of 5-Chloro-2-Nitroaniline
A significant proportion of healthcare professionals still tend to favor branded drugs
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
He has over two decades of rich experience in management consulting, advising and transforming leading generic pharmaceutical companies in India and global markets
Post this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.
ICICI Direct expects revenue CAGR of 35.6% over FY22-FY24E mainly due to the consolidation of Viatris business and they expect EBITDA margin expansion of 230bps and earnings CAGR of 64.8% over FY22-FY24E
With launches, continuing momentum in India, other branded markets and a pick-up in the US, Ajanta would deliver 12% revenue/PAT growth each over FY22-24
These bulk orders will contribute to the topline of the company as well as help in improving EBITDA of the company
Floods had forced the plans in Mahad to shut down
Subscribe To Our Newsletter & Stay Updated
